P. Merino, V. Mannucci, T. Tejero
3J = 5.6 Hz, 1 H), 1.10 (br., 3 H), 0.82 (s, 3 H) ppm. 13C NMR 7.62–7.57 (m, 2 H), 7.56–7.51 (m, 2 H), 7.48–7.22 (m, 14 H), 4.91
FULL PAPER
3
3
(100 MHz, CDCl3): δ = 173.2, 166.0, 141.2, 136.3, 132.9, 130.1, (dd, J = 8.2, 4.7 Hz, 1 H), 4.46 (dd, J = 8.6, 5.2 Hz, 1 H), 4.21–
2
3
129.6, 129.5, 128.7, 128.2, 128.1, 127.0, 126.5, 126.0, 109.2, 75.6,
67.7, 67.4, 29.6, 29.1, 26.5, 24.5 ppm (C-2 and C-6 of the piperidine
cycle could not be detected, probably due to the formation of a
conformational equilibrium). C30H31NO5 (485.57): calcd. C 74.21,
H 6.43, N 2.88; found C 74.38, H 6.60, N 2.72.
4.13 (m, 1 H), 3.80 (s, 3 H), 2.38 (ddd, J = 14.4, J = 8.2, 5.6 Hz,
2
3
2
1 H), 2.29 (ddd, J = 14.4, J = 8.6, 6.0 Hz, 1 H), 2.12 (ddd, J =
3
2
3
14.4, J = 7.5, 4.8 Hz, 1 H), 2.04 (ddd, J = 14.4, J = 7.4, 5.2 Hz,
1 H), 0.92 (s, 9 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 173.1,
172.9, 143.0, 135.7, 135.6, 135.5, 133.6, 133.5, 130.2, 129.8, 129.7,
128.3, 128.2, 127.7, 127.6, 126.9, 126.8, 126.6, 65.2, 56.5, 55.1, 52.4,
38.8, 34.3, 26.7, 19.0 ppm. C36H39NO4Si (577.79): calcd. C 74.84,
H 6.80, N 2.42; found C 74.64, H 6.66, N 2.35.
(2R,4S,6S)-N-Benzoyl-4-tert-butyldiphenylsiloxy-2-[(S)-2,2-di-
methyl-1,3-dioxolan-4-yl]-6-phenylpiperidine (41): The reaction of
35 (0.516 g, 1 mmol), as described for 32 in the synthesis of 39,
gave, after purification by radial chromatography (hexane/ethyl ace-
tate, 4:1; Rf = 0.26), pure 41 (0.477 g, 77%); oil. [α]2D0 = –82 (c =
1.81, CHCl3). 1H NMR (500 MHz, CDCl3): δ = 7.70–7.66 (m, 2
H), 7.64–7.60 (m, 2 H), 7.55–7.48 (m, 3 H), 7.47–7.40 (m, 5 H),
7.38–7.30 (m, 7 H), 7.27–7.21 (m, 1 H), 5.90 (br., 1 H), 4.41–4.31
(2S,4R,6R)-4-tert-Butyldiphenylsiloxy-2-[(S)-2,2-dimethyl-1,3-di-
oxolan-4-yl]-6-phenylpiperidine (44): The reaction of 33 (0.277 g,
1 mmol), as described for 32 in the synthesis of 35, afforded after
purification by radial chromatography (hexane/ethyl acetate, 4:1; Rf
= 0.62) pure 44 (0.490 g, 74%); oil. [α]2D0 = +45 (c = 0.84, CHCl3).
1H NMR (400 MHz, CDCl3): δ = 7.63–7.55 (m, 4 H), 7.39–7.25
(m, 6 H), 7.24–7.19 (m, 4 H), 7.18–7.12 (m, 1 H), 3.99 (t, 3J =
3
(m, 2 H), 4.06 (br., 1 H), 3.70 (dd, J = 7.6, 6.2 Hz, 1 H), 2.98 (t,
3J = 7.9 Hz, 1 H), 2.58 (dt, 2J = 14.1, 3J = 5.2 Hz, 1 H), 2.22 (ddd,
2J = 14.1, 3J = 7.7, 3.8 Hz, 1 H), 1.80 (ddd, 2J = 13.8, 3J = 7.7,
4.4 Hz, 1 H), 1.32–1.25 (m, 1 H), 1.28 (s, 3 H), 1.09 (s, 3 H), 1.04
(s, 9 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 172.9, 141.5,
137.0, 135.8, 135.5, 133.5, 133.3, 130.0, 129.9, 128.9, 128.0, 127.8,
127.7, 127.6, 126.8, 126.8, 126.3, 109.2, 76.0, 67.4, 65.5, 55.7, 50.9,
34.4, 34.0, 27.0, 26.4, 25.2, 19.0 ppm. C39H45NO4Si (619.87): calcd.
C 75.57, H 7.32, N 2.26; found C 75.51, H 7.39, N 2.22.
3
3
7.0 Hz, 1 H), 3.91 (td, J = 6.6, 3.8 Hz, 1 H), 3.85 (dd, J = 7.0,
3
2
6.2 Hz, 1 H), 3.69 (tt, J = 10.6, 4.4 Hz, 1 H), 3.39 (dd, J = 11.5,
3J = 2.4 Hz, 1 H), 2.73 (ddd, 2J = 11.9, 3J = 3.7, 2.4 Hz, 1 H), 1.86
2
3
2
3
(ddt, J = 12.2, J = 4.4, 2.2 Hz, 1 H), 1.70 (ddt, J = 11.9, J =
2
4.4, 2.2 Hz, 1 H), 1.63 (br., 1 H), 1.44 (q, J = 11.5 Hz, 1 H), 1.24
(s, 6 H), 1.08 (q, J = 11.5 Hz, 1 H), 0.96 (s, 9 H) ppm. 13C NMR
2
(100 MHz, CDCl3): δ = 144.6, 135.8, 134.4, 134.3, 129.7, 129.6,
128.4, 127.6, 127.2, 126.7, 108.7, 78.7, 71.1, 65.0, 59.0, 55.1, 44.6,
37.3, 27.0, 26.5, 25.3, 19.1 ppm. C32H41NO3Si (515.76): calcd. C
74.52, H 8.01, N 2.72; found C 74.77, H 8.14, N 2.90.
(2R,4S,6S)-N-Benzoyl-4-tert-butyldiphenylsiloxy-6-phenylpiper-
idine-2-carboxylic Acid (42): H5IO6 (0.180 g, 0.79 mmol) was added
to a well-stirred solution of 41 (0.477 g, 0.77 mmol) in diethyl ether
(10 mL) and the resulting suspension was stirred at room tempera-
ture for 4 h. After this time the mixture was filtered through a short
pad of silica gel and the filtrate was evaporated under reduced pres-
sure. The crude product was taken up in acetonitrile (3 mL) and
then added to a cooled (0 °C) and freshly prepared solution of
NaH2PO4 (0.022 g, 0.183 mmol) and sodium chlorite (0.099 g,
1.10 mmol) in water (2 mL). The resulting mixture was stirred for
5 min after which time H2O2 30 % (0.077 mL, 0.82 mmol) was
added. The stirring was maintained for an additional hour at 0 °C
after which time Na2SO3 (0.007 g, 0.05 mmol) was added. After
5 min of stirring the solution was acidified to pH 2–3 with 10%
HCl. The resulting solution was diluted with dichloromethane
(30 mL) and saturated aq. ammonium chloride. The organic layer
was separated, washed with brine (3ϫ50 mL), dried with magne-
sium sulfate, filtered and evaporated at reduced pressure. The crude
product was purified by radial chromatography (hexane/ethyl ace-
tate, 4:1; Rf = 0.07) to give pure 42 (0.282 g, 65%); oil. [α]2D0 = –6
(2S,4R,6R)-N-Benzoyl-4-tert-butyldiphenylsiloxy-2-[(S)-2,2-di-
methyl-1,3-dioxolan-4-yl]-6-phenylpiperidine (45): The reaction of
44 (0.382 g, 0.74 mmol), as described for 35 in the synthesis of 41,
afforded after purification by radial chromatography (hexane/ethyl
acetate, 4:1; Rf = 0.37) pure 45 (0.367 g, 80%); oil. [α]2D0 = +39 (c
= 0.79, CHCl3). 1H NMR (400 MHz, CDCl3, 55 °C): δ = 7.78–7.66
(m, 4 H), 7.52–7.20 (m, 14 H), 7.18–7.13 (m, 2 H), 5.44 (t, 3J =
2
7.0 Hz, 1 H), 4.30–4.13 (m, 3 H), 3.68–3.54 (m, 2 H), 2.49 (dt, J
= 14.4, J = 7.3 Hz, 1 H), 2.25–2.15 (m, 1 H), 2.08–1.99 (m, 1 H),
3
2
3
1.94 (dt, J = 13.5, J = 6.6 Hz, 1 H), 1.21 (s, 3 H), 1.19 (s, 3 H),
1.11 (s, 9 H) ppm. 13C NMR (100 MHz, CDCl3, 55 °C; mixture of
conformers): δ = 173.1, 142.3, 137.1, 136.0, 135.9, 134.2, 134.1,
133.5, 130.2, 129.9, 129.8, 129.1, 128.5, 128.2, 127.7, 127.6, 127.1,
126.9, 126.0, 109.4, 77.5, 67.4, 66.7, 54.4, 35.4, 32.7, 29.7, 27.1,
26.7, 25.3, 19.2 ppm. C39H45NO4Si (619.87): calcd. C 75.57, H
7.32, N 2.26; found C 75.46, H 7.28, N 2.41.
1
Methyl (2S,4R,6R)-N-Benzoyl-4-tert-butyldiphenylsiloxy-6-phenyl-
piperidine-2-carboxylate (ent-43): Starting from 45 (0.367 g,
0.59 mmol) and applying, sequentially, the methodologies used to
synthesize 42 and 43, pure ent-43 (0.198 g, 58%) was obtained; oil.
[α]2D0 = –39 (c = 0.83, CHCl3). The Rf, m.p. and NMR data were
identical to those found for its enantiomer 43.
(c = 0.42, CHCl3). H NMR (500 MHz, CDCl3): δ = 8.80 (br., 1
H), 7.78–7.52 (m, 5 H), 7.50–7.30 (m, 12 H), 7.29–7.19 (m, 3 H),
3
3
4.97 (t, J = 5.9 Hz, 1 H), 4.43 (dd, J = 9.6, 5.4 Hz, 1 H), 4.22–
4.14 (m, 1 H), 2.41 (ddd, 2J = 14.6, 3J = 6.8, 5.6 Hz, 1 H), 2.33
(dt, 2J = 14.6, 3J = 7.9 Hz, 1 H), 2.19–2.08 (m, 2 H), 0.99 (s, 9
H) ppm. 13C NMR (125 MHz, CDCl3): δ = 176.5, 173.7, 142.7,
135.8, 135.7, 135.6, 135.4, 133.8, 133.7, 130.4, 129.9, 129.8, 128.4,
127.8, 127.7, 127.0, 126.9, 126.7, 65.4, 57.3, 55.4, 38.7, 33.8, 26.8,
19.0 ppm. C35H37NO4Si (563.76): calcd. C 74.57, H 6.62, N 2.48;
found C 74.44, H 6.78, N 2.42.
Methyl (2R,4S,6S)-6-Phenyl-7-oxa-1-azabicyclo[2.2.1]heptane-2-
carboxylate (46): Starting from 20 (0.6 g, 2.18 mmol) and applying
the methodology used to synthesize 43, pure 46 was obtained after
radial chromatography (hexane/ethyl acetate, 4:1; Rf = 0.38); white
Methyl (2R,4S,6S)-N-Benzoyl-4-tert-butyldiphenylsiloxy-6-phenyl- solid, m.p. 88–89 °C. [α]2D0 = –6 (c = 1.49, CHCl3). 1H NMR
piperidine-2-carboxylate (43): Compound 42 (0.282 g, 0.50 mmol)
was dissolved in methanol (5 mL) and treated with TMSCHN2
(0.75 mmol) under vigorous stirring. After 3 h the solvent was elim-
inated under reduced pressure and the resulting crude product was
purified by radial chromatography (hexane/ethyl acetate, 4:1; Rf =
0.33) to give pure 43 (0.260 g, 90%); oil. [α]2D0 = –14 (c = 1.24,
(400 MHz, CDCl3): δ = 7.35–7.30 (m, 2 H), 7.26–7.20 (m, 2 H),
3
3
7.17–7.12 (m, 1 H), 5.00 (t, J = 4.9 Hz, 1 H), 3.89 (dd, J = 8.3,
3
5.0 Hz, 1 H), 3.69 (s, 3 H), 3.64 (dd, J = 8.6, 4.7 Hz, 1 H), 2.32
(dtd, 2J = 11.9, 3J = 4.8, 2.7 Hz, 1 H), 2.13 (dd, 2J = 11.9, 3J =
2
3
8.3 Hz, 1 H), 2.00–1.93 (m, 1 H), 1.90 (dd, J = 11.9, J = 8.6 Hz,
1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 171.5, 143.2, 128.4,
CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.72–7.66 (m, 2 H), 127.0, 126.7, 78.7, 70.1, 68.3, 52.6, 42.4, 36.5 ppm. C13H15NO3
3956
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 3943–3959